Related references
Note: Only part of the references are listed.3-Hydroxy-3-Methylglutaryl-COA Reductase Inhibitors and Phosphodiesterase Type V Inhibitors Attenuate Right Ventricular Pressure and Remodeling in a Rat Model of Pulmonary Hypertension
Mitsutoshi Satoh et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2016)
Neprilysin Null Mice Develop Exaggerated Pulmonary Vascular Remodeling in Response to Chronic Hypoxia
Edward C. Dempsey et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment
Danielle L. Burke et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Update in Pulmonary Hypertension 2008
Marc Humbert
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Collagen-related gene and protein expression changes in the lung in response to chronic hypoxia
Kristine D. Estrada et al.
BIOMECHANICS AND MODELING IN MECHANOBIOLOGY (2009)
Propylthiouracil Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
Cheuk-Kwan Sun et al.
CIRCULATION JOURNAL (2009)
Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway
Matthias Brock et al.
CIRCULATION RESEARCH (2009)
Interleukin-6 Overexpression Induces Pulmonary Hypertension
M. Kathryn Steiner et al.
CIRCULATION RESEARCH (2009)
CPU0213, A NON-SELECTIVE ETA/ETB RECEPTOR ANTAGONIST, IMPROVES PULMONARY ARTERIOLAR REMODELING OF MONOCROTALINE-INDUCED PULMONARY HYPERTENSION IN RATS
Bing Cui et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension
Liang Xia et al.
CYTOTHERAPY (2009)
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
M. J. Overbeek et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats
Anna Csiszar et al.
HYPERTENSION (2009)
Effects of Roflumilast, a Phosphodiesterase-4 Inhibitor, on Hypoxia- and Monocrotaline-Induced Pulmonary Hypertension in Rats
Mohamed Izikki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association
Vallerie V. McLaughlin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Diagnosis and Assessment of Pulmonary Arterial Hypertension
David B. Badesch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Pathology of Pulmonary Arterial Hypertension
Rubin M. Tuder
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-I dependent pathway in rats
Hsao-Hsun Hsu et al.
RESPIRATORY RESEARCH (2009)
Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice
Laurent Savale et al.
RESPIRATORY RESEARCH (2009)
Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension
Kendall S. Hunter et al.
AMERICAN HEART JOURNAL (2008)
Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension
Kewal Asosingh et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Changes in the structure-function relationship of elastin and its impact on the proximal pulmonary arterial mechanics of hypertensive calves
Steven R. Lammers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature
David B. Frank et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions
James West et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension
S. M. Majka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone
Noriyuki Homma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling
Eva Nozik-Grayck et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Update in pulmonary arterial hypertension 2007
Marc Humbert
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats
Hiroaki Obata et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
The Vasoactive Intestinal Peptide Gene Is a Key Modulator of Pulmonary Vascular Remodeling and Inflammation
Sami I. Said
Neural Signaling: Opportunities for Novel Diagnostic Approaches and Therapies (2008)
Molecular Mechanisms of Pulmonary Arterial Hypertension Role of Mutations in the Bone Morphogenetic Protein Type II Receptor
Rachel. J. Davies et al.
CHEST (2008)
Genetic ablation of the Bmpr2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension
Kwon-Ho Hong et al.
CIRCULATION (2008)
Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension
Hossein A. Ghofrani et al.
CIRCULATION (2008)
Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling
Martina Klein et al.
CIRCULATION (2008)
Emerging concepts and translational priorities in pulmonary arterial hypertension
Evangelos D. Michelakis et al.
CIRCULATION (2008)
Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome
Nazzareno Galie et al.
DRUGS (2008)
Murine pulmonary response to chronic hypoxia is strain specific
Yuji Tada et al.
EXPERIMENTAL LUNG RESEARCH (2008)
Right heart function and haemodynamics in pulmonary hypertension
A. R. Hemnes et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension
Tomohiro Kato et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Pathogenic mechanisms of pulmonary arterial hypertension
Stephen Y. Chan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
A long-acting and highly selective prostacyclin receptor agonist prodrug, 2-{4-[(5,6-diphenylpyrazin-2yl)(isopropyl) amino]butoxy}-N-(methylsulfonyl)acetamide(NS-304), ameliorates rat pulmonary hypertension with unique relaxant responses of its active form, {4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy} acetic acid (MRE-269), on rat pulmonary artery
Keiichi Kuwano et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Stiffening of the Extrapulmonary Arteries From Rats in Chronic Hypoxic Pulmonary Hypertension
E. S. Drexler et al.
JOURNAL OF RESEARCH OF THE NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY (2008)
A protocol for phenotypic detection and characterization of vascular cells of different origins in a lung neovascularization model in rodents
Rosemary C. Jones et al.
NATURE PROTOCOLS (2008)
Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension
Liliana Moreno-Vinasco et al.
PHYSIOLOGICAL GENOMICS (2008)
2-ethoxyestradiol is antimitogenic and attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling
Stevan P. Tofovic et al.
VASCULAR PHARMACOLOGY (2008)
Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension
C. Tji-Joong Gan et al.
CHEST (2007)
Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension
R. James White et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Adenoassociated virus-mediated prostacyclin synthase expression prevents pulmonary arterial hypertension in rats
Takayuki Ito et al.
HYPERTENSION (2007)
Dosage-dependent requirement of BNW type II receptor for maintenance of vascular integrity
Dong Liu et al.
BLOOD (2007)
Effects of combined therapy with a Rho-kinase inhibitor and prostacyclin on monocrotaline-induced pulmonary hypertension in rats
Shunsuke Tawara et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted
Sebastien Bonnet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling
Laimute Taraseviciene-Stewart et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology
Alejandro Macchia et al.
AMERICAN HEART JOURNAL (2007)
NFATc3 mediates chronic hypoxia-induced pulmonary arterial remodeling with α-actin up-regulation
Sergio de Frutos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Dendritic cell recruitment in lesions of human and experimental pulmonary hypertension
F. Perros et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Genetics and mediators in pulmonary arterial hypertension
Eric D. Austin et al.
CLINICS IN CHEST MEDICINE (2007)
Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice
Renate Paddenberg et al.
RESPIRATORY RESEARCH (2007)
Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease
Marilyne Levy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction
Syed R. Baber et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Effects on cytokines and histology by treatment with the ace inhibitor captopril and the antioxidant retinoic acid in the monocrotaline model of experimentally induced lung fibrosis
Richard C. Baybutt et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Pulmonary vascular remodeling in isolated mouse lungs: Effects on pulsatile pressure-flow relationships
Holly A. Tuchscherer et al.
JOURNAL OF BIOMECHANICS (2007)
Pathology of pulmonary hypertension
Rubin M. Tuder et al.
CLINICS IN CHEST MEDICINE (2007)
Right ventricular function and failure - Report of a National Heart, lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure
Norbert F. Voelkel et al.
CIRCULATION (2006)
Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension
Laimute Taraseviciene-Stewart et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Hypoxia-induced pulmonary vascular remodeling - Cellular and molecular mechanisms
Kurt R. Stenmark et al.
CIRCULATION RESEARCH (2006)
HIV-1 nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques
John C. Marecki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
An abnormal mitochondrial-hypoxia inducible factor-1α-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats -: Similarities to human pulmonary arterial hypertension
Sébastien Bonnet et al.
CIRCULATION (2006)
Pulmonary vascular resistance and impedance in isolated mouse lungs: Effects of pulmonary emboli
HA Tuchscherer et al.
ANNALS OF BIOMEDICAL ENGINEERING (2006)
Role of the adventitia in pulmonary vascular remodeling
KR Stenmark et al.
PHYSIOLOGY (2006)
Noninvasive Doppler tissue measurement of pulmonary artery compliance in children with pulmonary hypertension
K Dyer et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2006)
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice
L Long et al.
CIRCULATION RESEARCH (2006)
Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat
T Nagaoka et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension
S Mahapatra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage
MG Frid et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling
R Dumitrascu et al.
CIRCULATION (2006)
Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension
HL Zhou et al.
LABORATORY INVESTIGATION (2006)
One hundred years of research in the pathogenesis of pulmonary hypertension
A Zaiman et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension
G Kwapiszewska et al.
RESPIRATORY RESEARCH (2005)
Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmonary hypertension
SL Merklinger et al.
CIRCULATION RESEARCH (2005)
Treatment of severe pulmonary hypertension: A bradykinin receptor 2 agonist B9972 causes reduction of pulmonary artery pressure and right ventricular hypertrophy
LT Taraseviciene-Stewart et al.
PEPTIDES (2005)
Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice
YL Song et al.
CIRCULATION (2005)
Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension
SL Merklinger et al.
CIRCULATION (2005)
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
O Sitbon et al.
CIRCULATION (2005)
Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats - A new model of severe pulmonary arterial hypertension
DD Ivy et al.
CIRCULATION (2005)
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension
MS McMurtry et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats
C Guignabert et al.
CIRCULATION (2005)
Mechanisms, pathophysiology, and therapy of arterial stiffness
SJ Zieman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
被撤回的出版物: Arterial hemodynamics in patients after Kawasaki disease (Retracted article. See vol. 125, pg. E1020, 2012)
H Senzaki et al.
CIRCULATION (2005)
Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells - Efficacy of combined cell and eNOS gene therapy in established disease
YDD Zhao et al.
CIRCULATION RESEARCH (2005)
Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension
RD Machado et al.
CIRCULATION (2005)
Transforming growth factor-β receptor mutations and pulmonary arterial hypertension in childhood
RE Harrison et al.
CIRCULATION (2005)
The right ventricle in pulmonary hypertension
KM Chin et al.
CORONARY ARTERY DISEASE (2005)
Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle
J West et al.
CIRCULATION RESEARCH (2004)
Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats
LT Vaszar et al.
PHYSIOLOGICAL GENOMICS (2004)
Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells
NJ Davie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats
K Abe et al.
CIRCULATION RESEARCH (2004)
The orally active nonpeptide selective endothelin ETA receptor antagonist YM598 prevents and reverses the development of pulmonary hypertension in monocrotaline-treated rats
H Yuyama et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia
H Beppu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy
S Greenway et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Cellular and molecular pathobiology of pulmonary arterial hypertension
M Humbert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Pathologic assessment of vasculopathies in pulmonary hypertension
GG Pietra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Clinical classification of pulmonary hypertension
G Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats
T Itoh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Extraction of pulmonary vascular compliance, pulmonary vascular resistance, and right ventricular work from single-pressure and Doppler flow measurements in children with pulmonary hypertension: A new method for evaluating reactivity - In vitro and clinical studies
CE Weinberg et al.
CIRCULATION (2004)
Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis
MS McMurtry et al.
CIRCULATION RESEARCH (2004)
Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells
T Nishimura et al.
CIRCULATION (2003)
Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension
B Rondelet et al.
CIRCULATION (2003)
Hypoxia induces different genes in the lungs of rats compared with mice
Y Hoshikawa et al.
PHYSIOLOGICAL GENOMICS (2003)
Pulmonary arterial hypertension in children
A Widlitz et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension
P Wauthy et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2003)
DA-8159, a new PDE5 inhibitor, attenuates the development of compensatory right ventricular hypertrophy in a rat model of pulmonary hypertension
KK Kang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2003)
Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats
T Nishimura et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Dexfenfluramine protects against pulmonary hypertension in rats
Y Mitani et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
被撤回的出版物: Ventricular afterload and ventricular work in Fontan circulation - Comparison with normal two-ventricle circulation and single-ventricle circulation with Blalock-Taussig shunts (Retracted article. See vol. 125, pg. E1020, 2012)
H Senzaki et al.
CIRCULATION (2002)
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor
C Atkinson et al.
CIRCULATION (2002)
A bradykinin antagonist and a caspase inhibitor prevent severe pulmonary hypertension in a rat model
L Taraseviciene-Stewart et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis
RM Tuder et al.
JOURNAL OF PATHOLOGY (2001)
The pathology of pulmonary artery hypertension
B Meyrick
CLINICS IN CHEST MEDICINE (2001)
Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats
S Kanno et al.
CIRCULATION (2001)
The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor
N Ambartsumian et al.
ONCOGENE (2001)
Gene expression patterns in the lungs of patients with primary pulmonary hypertension - A gene microarray analysis
MW Geraci et al.
CIRCULATION RESEARCH (2001)
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
L Taraseviciene-Stewart et al.
FASEB JOURNAL (2001)
40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats
T Nishimura et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Vascular remodeling in experimentally induced subacute canine pulmonary hypertension
R Gust et al.
EXPERIMENTAL LUNG RESEARCH (2001)
Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats
JL Faul et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension - A morphometric and immunohistochemical study
ES Yi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Systemic lobar shunting induces advanced pulmonary vasculopathy
M Bousamra et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2000)
Pulse pressure and risk for myocardial infarction and heart failure in the elderly
V Vaccarino et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Pulmonary expression of early growth response-1: biphasic time course and effect of oxygen concentration
SF Yan et al.
JOURNAL OF APPLIED PHYSIOLOGY (2000)
Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension
S Hirose et al.
PATHOLOGY INTERNATIONAL (2000)
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
KN Cowan et al.
NATURE MEDICINE (2000)
Hypertension and arterial stiffness: The atherosclerosis risk in communities study
DK Arnett et al.
AMERICAN JOURNAL OF HYPERTENSION (2000)
Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?
NF Voelkel et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
